Vaccinex, Inc. Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease)
Vaccinex, Inc. (VCNX) reported Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) of -$369.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease · last filed 2019-03-13
- Vaccinex, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2018-12-31 was $0.00.
- Vaccinex, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2018-09-30 was -$31.00K.
- Vaccinex, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for fiscal 2018 was -$369.00K.
- Vaccinex, Inc. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for fiscal 2017 was -$3.74M.
| Period end | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 3 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 6 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 9 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$31.00K derived: sum of 2 quarters · filed 2019-03-13 | -$369.00K 10-K · filed 2019-03-13 | |
| 2018-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$369.00K 10-Q · filed 2018-11-13 | ||
| 2018-06-30 | -$338.00K 10-Q · filed 2018-08-14 | |||
| 2017-12-31 | -$3.74M 10-K · filed 2019-03-13 |